. Author manuscript; available in PMC: 2012 Jan 1.

Published in final edited form as: J Steroid Biochem Mol Biol. 2010 Oct 16;123(1-2):30–36. doi: 10.1016/j.jsbmb.2010.10.002

Table 2.

VDR expression characteristics stratified by patient status at last follow-up

VDR expression characteristic	Nuclear VDR			Cytoplasmic VDR
VDR expression characteristic	Deceased n=44	Alive n=29	P^b	Deceased n=44	Alive n=29	P^b
Intensity			0.721			0.974
0	12 (27.3%)	6 (20.7%)		11 (25.0%)	7 (24.1%)
1	11 (25.0%)	6 (20.7%)		16 (36.4%)	12 (41.4%)
2	11 (25.0%)	7 (24.1%)		8 (18.2%)	5 (17.2%)
3	10 (22.7%)	10 (34.5%)		9 (20.5%)	5 (17.2%)
Percentage positive cells^a			0.372			0.983
0	12 (27.3%)	6 (20.7%)		11 (25.0%)	7 (24.1%)
5-15	6 (13.6%)	6 (20.7%)		11 25.0%)	7 (24.1%)
20-50	10 (22.7%)	3 (10.3%)		6 (13.6%)	3 (10.3%)
55-80	9 (20.5%)	5 (17.2%)		7 (15.9%)	6 (20.7%)
85-100	7 (15.9%)	9 (31.0%)		9 (20.5%)	6 (20.7%)

VDR: Vitamin D receptor

Percentage of tumor cells expressing VDR was recorded in 5% increments

P values calculated using χ² test